Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zelal Jaber Kharaba, Manal Ali Buabeid & Yaseen Abd Alfoteih. (2020) Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system. Critical Reviews in Toxicology 50:6, pages 491-512.
Read now
Read now
Nur-Vaizura Mohamad, Sok Kuan Wong, Wan Nuraini Wan Hasan, James Jam Jolly, Mohd Fozi Nur-Farhana, Soelaiman Ima-Nirwana & Kok-Yong Chin. (2019) The relationship between circulating testosterone and inflammatory cytokines in men. The Aging Male 22:2, pages 129-140.
Read now
Read now
Kazuyoshi Shigehara, Hiroyuki Konaka, Masashi Ijima, Takahiro Nohara, Kazutaka Narimoto, Koji Izumi, Yoshifumi Kadono, Yasuhide Kitagawa, Atsushi Mizokami & Mikio Namiki. (2016) The correlation between highly sensitive C-reactive protein levels and erectile function among men with late-onset hypogonadism. The Aging Male 19:4, pages 239-243.
Read now
Read now
Abraham Morgentaler, Allison Feibus & Neil Baum. (2015) Testosterone and cardiovascular disease – the controversy and the facts. Postgraduate Medicine 127:2, pages 159-165.
Read now
Read now
Articles from other publishers (23)
Ali Mohammadrezaei, Abnoos Mokhtari Ardekani, Mahdieh Abbasalizad-Farhangi, Mehran Mesgari-Abbasi & Reihaneh Mousavi. (2023) Association Between Sex Hormone-Binding Globulin, Atherogenic Indices of Plasma Among Young Sedentary Males. Nutrition and Metabolic Insights 16, pages 117863882311550.
Crossref
Crossref
Jacques Baillargeon, Yong‐Fang Kuo, Jordan Westra, David S. Lopez, Randall J. Urban, Stephen B. Williams & Mukaila A. Raji. (2022) Association of testosterone therapy with disease progression in older males with COVID‐19. Andrology 10:6, pages 1057-1066.
Crossref
Crossref
Amar Osmancevic, Kristin Ottarsdottir, Margareta Hellgren, Ulf Lindblad & Bledar Daka. (2022) High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study. Endocrine Connections 11:7.
Crossref
Crossref
Olaya Dios, Leticia Herrero, Claudia Vales‐Villamarín, Ignacio Mahíllo‐Fernández, Leandro Soriano‐Guillén & Carmen Garcés. (2020) Sex steroid hormones, leptin, and high‐sensitivity C‐reactive protein levels in adolescents. Andrology 9:3, pages 829-836.
Crossref
Crossref
Zelal Jaber Kharaba, Manal Ali Buabeid, Nihal A. Ibrahim, Feras Jassim Jirjees, Hala Jehad Al Obaidi, Adnan Kaddaha, Laleh Khajehkarimoddini & Yassen Alfoteih. (2020) Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events. Biomedicine & Pharmacotherapy 129, pages 110423.
Crossref
Crossref
Thiago Gagliano-Jucá & Shehzad Basaria. (2019) Testosterone replacement therapy and cardiovascular risk. Nature Reviews Cardiology 16:9, pages 555-574.
Crossref
Crossref
Vittorio Emanuele Bianchi. (2019) The Anti-Inflammatory Effects of Testosterone. Journal of the Endocrine Society 3:1, pages 91-107.
Crossref
Crossref
Abdulmaged Traish, Jose Bolanos, Sunil Nair, Farid Saad & Abraham Morgentaler. (2018) Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence. Journal of Clinical Medicine 7:12, pages 549.
Crossref
Crossref
Thiago Gagliano-Jucá, M Furkan Burak, Karol M Pencina, Zhuoying Li, Robert R Edwards, Thomas G Travison & Shehzad Basaria. (2018) Metabolic Changes in Androgen-Deprived Nondiabetic Men With Prostate Cancer Are Not Mediated by Cytokines or aP2. The Journal of Clinical Endocrinology & Metabolism 103:10, pages 3900-3908.
Crossref
Crossref
Lina Schiffer, Punith Kempegowda, Wiebke Arlt & Michael W O’Reilly. (2017) MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. European Journal of Endocrinology 177:3, pages R125-R143.
Crossref
Crossref
Jerry Yu, Vanessa A. Ravel, Amy S. You, Elani Streja, Matthew B. Rivara, Praveen K. Potukuchi, Steven M. Brunelli, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh & Connie M. Rhee. (2017) Association between Testosterone and Mortality Risk among U.S. Males Receiving Dialysis. American Journal of Nephrology 46:3, pages 195-203.
Crossref
Crossref
Jacques Baillargeon, Soham Al Snih, Mukaila A. Raji, Randall J. Urban, Gulshan Sharma, Melinda Sheffield-Moore, David S. Lopez, Gwen Baillargeon & Yong-Fang Kuo. (2016) Hypogonadism and the risk of rheumatic autoimmune disease. Clinical Rheumatology 35:12, pages 2983-2987.
Crossref
Crossref
Monique S. Tanna, Arthur Schwartzbard, Jeffery S. Berger, James Underberg, Eugenia Gianos & Howard S. Weintraub. (2016) Management of Hypogonadism in Cardiovascular Patients. Urologic Clinics of North America 43:2, pages 247-260.
Crossref
Crossref
F. Saad, A. Haider & L. Gooren. (2016) Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy - a series of 15 case reports. Andrologia 48:3, pages 341-346.
Crossref
Crossref
J. Abram McBride, Culley C. CarsonIIIIII & Robert M. Coward. (2015) Testosterone deficiency in the aging male. Therapeutic Advances in Urology 8:1, pages 47-60.
Crossref
Crossref
Kevin Matthew Yen Bing Leung, Khalid Alrabeeah & Serge Carrier. (2015) Update on Testosterone Replacement Therapy in Hypogonadal Men. Current Urology Reports 16:8.
Crossref
Crossref
Mahmoud Nasser, Ahmad Haider, Farid Saad, Winfried Kurtz, Gheorghe Doros, Monika Fijak, Linda Vignozzi & Louis Gooren. (2015) Testosterone therapy in men with Crohn’s disease improves the clinical course of the disease: data from long-term observational registry study. Hormone Molecular Biology and Clinical Investigation 22:3, pages 111-117.
Crossref
Crossref
Monique S. Tanna, Arthur Schwartzbard, Jeffery S. Berger, Joseph Alukal & Howard Weintraub. (2015) The Role of Testosterone Therapy in Cardiovascular Mortality: Culprit or Innocent Bystander?. Current Atherosclerosis Reports 17:3.
Crossref
Crossref
K. K. Tsilidis, S. Rohrmann, K. A. McGlynn, S. J. Nyante, D. S. Lopez, G. Bradwin, M. Feinleib, C. E. Joshu, N. Kanarek, W. G. Nelson, E. Selvin & E. A. Platz. (2013) Association between endogenous sex steroid hormones and inflammatory biomarkers in US men. Andrology 1:6, pages 919-928.
Crossref
Crossref
Joe Butchart, Brian Birch, Ramy Bassily, Laura Wolfe & Clive Holmes. (2013) Male Sex Hormones and Systemic Inflammation in Alzheimer Disease. Alzheimer Disease & Associated Disorders 27:2, pages 153-156.
Crossref
Crossref
Cristina Ferrandis-Cortes, José M. Martínez-Jabaloyas, Nelson A. Díez-Calzadilla, José A. Hernández-Medina & Pascual Chuan-Nuez. (2013) Cardiovascular Risk Assessment Using High-Sensitivity C-Reactive Protein in Patients with Erectile Dysfunction. Urologia Internationalis 91:2, pages 187-191.
Crossref
Crossref
Farid Saad. (2012) Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?. Diabetes/Metabolism Research and Reviews 28, pages 52-59.
Crossref
Crossref
Pierre Olivier LangDimitrios SamarasNikolaos Samaras. (2012) Testosterone Replacement Therapy in Reversing “Andropause”: What Is the Proof-of-Principle?. Rejuvenation Research 15:5, pages 453-465.
Crossref
Crossref